Evidence map›Paper›PMID 31957474›Full record

Observational studyCirculation. Cardiovascular quality and outcomes2020

Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data.

Peter Cram, Saket Girotra, John Matelski, Maria Koh, Bruce E Landon, Lu Han, Douglas S Lee, Dennis T Ko

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Circulation. Cardiovascular quality and outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Peter CramDepartment of Medicine (P.C., D.S.L., D.T.K.), University of Toronto, ON.
Saket GirotraDepartment of Medicine, University of Iowa (S.G.).
John MatelskiDivision of General Internal Medicine and Geriatrics, Sinai Health System and University Health Network, Toronto, ON (P.C., J.M.).
Maria KohICES, Toronto, ON (P.C., M.K., L.H., D.S.L., D.T.K.).
Bruce E LandonDivision of General Medicine, Department of Health Care Policy, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA (B.L.).
Lu HanICES, Toronto, ON (P.C., M.K., L.H., D.S.L., D.T.K.).
Douglas S LeeDepartment of Medicine (P.C., D.S.L., D.T.K.), University of Toronto, ON.
Dennis T KoDepartment of Medicine (P.C., D.S.L., D.T.K.), University of Toronto, ON.
Beth Israel Deaconess Medical Center · USEuropean Observatory on Health Systems and Policies · BESinai Health System · CASunnybrook Health Science Centre · CAUniversity Health Network · CAUniversity of Iowa · US

Funding

Comparing hospitalization rates, outcomes, and treatment intensity for elderly patients across OECD countriesR01AG058878 · NIA · HARVARD MEDICAL SCHOOL · PI Peter M Cram, Bruce E. Landon · 2019 to 2026
$3.4M
Post-Resuscitation Care and Survival After In-hospital Cardiac ArrestK08HL122527 · NHLBI · UNIVERSITY OF IOWA · PI GIROTRA, SAKET · 2014 to 2018
$731k
Natural Language Processing to Develop a Peripheral Artery Disease Registry in the Veterans Affairs Healthcare SystemI21HX002365 · VA · IOWA CITY VA MEDICAL CENTER · PI GIROTRA, SAKET · 2018 to 2019
–
HSRD VA I21 HX002365NHLBI NIH HHS K08 HL122527NIA NIH HHS R01 AG058878
6 · The paper itself

Abstract

backgroundEndovascular aortic aneurysm repair (EVAR), left ventricular assist device (LVAD), and transcatheter aortic valve replacement (TAVR) are expensive cardiovascular technologies with potential to benefit large numbers of patients. There are few population-based studies comparing utilization between countries. Our objective was to compare patient characteristics and utilization patterns of EVAR, LVAD, and TAVR in Ontario, Canada, and New York State, United States. METHODS AND

resultsWe performed a retrospective cohort study using administrative data to identify all adults who received EVAR, LVAD, or TAVR in Ontario and New York between 2012 and 2015. We compared socio-demographics of EVAR, LVAD, and TAVR recipients in Ontario and New York. We compared standardized utilization rates between jurisdictions for each procedure. We identified 3295 EVAR recipients from Ontario and 6236 from New York (mean age 74.6 versus 74.5 years;

conclusionsWe observed significantly higher utilization of EVAR, LVAD, and TAVR in New York compared to Ontario. Our results highlight important differences in how 2 different countries are using advanced cardiovascular therapies.

Indexed as

Administrative Claims, HealthcareAgedAged, 80 and overCardiovascular DiseasesComorbidityDatabases, FactualEndovascular ProceduresFemaleHealthcare DisparitiesHealth StatusHeart-Assist DevicesHumansMaleMiddle AgedNew YorkOntarioCanadaheart-assist devicespopulationtranscatheter aortic valve replacementUnited States

Identifiers

PMID31957474
PMCPMC7006709
OpenAlexW3004051918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.